Welcome To MedWorld Advisors!

These are just a few of the AI trends we forecast for 2025. We’re energized and excited to see how improvements and innovations in AI will continue to improve healthcare.

As the backbone of MedTech manufacturing, OEM suppliers continued to grow in 2024.

2024 presented a positive M&A environment for profitable Healthcare companies with a growth story, a trajectory expected to continue into 2025.

The orthopedic and spine industries this year underwent rapid consolidation through strategic M&A and partnerships.

In a somewhat unexpected move with positive implications for the MedTech industry, the Federal Reserve (Fed) in September opted for a 0.5% interest rate cut.

Selling your business is usually the penultimate milestone in a business owner’s career. A lot depends on its success, including financial longevity, continued legacy and even personal pride. On this episode, hear Dave discuss common mistakes as well as best practices for avoiding those mistakes.

Hosted by our founders CEO Florence Joffroy-Black, and Managing Director Dave Sheppard, watch the webinar to find out how M&A changes the MedTech landscape and its impacts on those involved in manufacturing medical devices and equipment.

From our perspective in working with private equity (PE) and strategic companies in 2024, mergers and acquisitions (M&A) continues to be highly active in medtech.

In our October column in ODT Magazine, we discuss how ASCs foster technological innovation that benefits both orthopedic implant developers and the centers themselves.

The election will stimulate more activity—depending, of course, on the political party that wins the presidency and control of the U.S. Congress.